ENZY: Enzymatica AB (publ) - Summary | Jitta

Enzymatica AB (publ)

SWE:ENZY

Price
kr2.43
Loss Chance
54.1%
2.86JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
27 / 107
255 / 616
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (45)
Recent Business Performance (62)
Financial Strength (35)
Return to Shareholders (0)
Competitive Advantage (41)
Jitta Signs
Recent Business PerformanceEarning Growth Last Quarter (YoY)
Revenue and EarningEarning loss detected in 2025
Operating MarginInconsistent
New Share IssuedMore than 50% in 5 years
CapExVery High
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
2.86
100.00%
2.16
102.25%
2.89
152.39%
Pharmaceuticals
6.20
170.39%
2.06
100.00%
1.77
100.00%
COMPANY DESCRIPTION
Enzymatica AB (publ), a life science company, develops and sells medical devices for infection-related diseases. The company’s product includes ColdZyme, a mouth spray that protects against the upper respiratory viruses that can cause cold and flu symptoms. It also provides enzyme formulations for skin care. The company was incorporated in 2007 and is headquartered in Lund, Sweden.